X-ALD
Clinical trials for X-ALD explained in plain language.
Never miss a new study
Get alerted when new X-ALD trials appear
Sign up with your email to follow new studies for X-ALD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Spinal injection gene therapy tested for rare nerve disease
Disease control TerminatedThis study tested a one-time gene therapy injection into the spinal fluid for adults with a rare, progressive nerve disease called adrenomyeloneuropathy (AMN). The goal was to see if delivering a working copy of a faulty gene could be safe and potentially slow down the worsening …
Matched conditions: X-ALD
Phase: PHASE1, PHASE2 • Sponsor: SwanBio Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Researchers map the slow decline of rare nerve disease
Knowledge-focused TerminatedThis study aimed to better understand how a rare, inherited nerve disorder called adrenomyeloneuropathy (AMN) gets worse over time. Researchers followed 65 adult men with AMN, tracking their walking ability and quality of life through regular check-ups. The goal was to gather det…
Matched conditions: X-ALD
Sponsor: SwanBio Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC